Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants-Reference-Cited by-同舟云学术

Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants

Published:2020-03-27 Issue:1 Volume:89 Page:217-222
ISSN:0031-3998
Container-title:Pediatric Research
language:en
Short-container-title:Pediatr Res

Author:

Wang Der-Shiun,Yu Chih-Hsiang,Lin Chien-Yu,Chang Ya-Hsuan,Lin Kai-Hsin,Lin Dong-Tsamn,Jou Shiann-Tarng,Lu Meng-Yao,Chang Hsiu-Hao,Lin Shu-Wha,Chen Hsuan-Yu,Yang Yung-Li

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://www.nature.com/articles/s41390-020-0868-8.pdf

Reference37 articles.

1. Relling, M. V. et al. Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update. Clin. Pharmacol. Ther. 105, 1095–1105 (2019).

2. Sutiman, N. et al. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients. Pharmacogenom. J. 19, 31–43 (2018).

3. Gerbek, T. et al. Role of TPMT and ITPA variants in mercaptopurine disposition. Cancer Chemother. Pharmacol. 81, 579–586 (2018).

4. Tanaka, Y. et al. Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia. Pharmacogenom. J. 18, 275–280 (2018).

5. Liu, C. et al. Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity. Cancer Chemother. Pharmacol. 80, 287–293 (2017).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of Deleterious SNPs in NUDT15 Gene Related to Acute Lymphoblastic Leukemia by using Bioinformatics Tools;İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi;2024-01-05

2. Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia;Cancer Chemotherapy and Pharmacology;2023-05-31

3. Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia;Scientific Reports;2023-01-10

4. The heterozygous NUDT15 variant is not associated with the severity of 6-mercaptopurine-related side effects in early intensification therapy for childhood acute lymphoblastic leukemia;EJC Paediatric Oncology;2023

5. Prominence of NUDT15 genetic variation associated with 6‐mercaptopurine tolerance in a genome‐wide association study of Japanese children with acute lymphoblastic leukaemia;British Journal of Haematology;2022-08-12